Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 701–800 of 1,000
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 45
“The factors forkhead box protein O1 (FOXO1) can also promote the transcription of gluconeogenic enzyme genes such as glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK1), which in turn leads to elevating gluconeogenesis [73].”
BackgroundChen, Y.-R., Lai, Y.-L., Lin, S., Li, X.-T., Fu, Y., & Xu, W. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2412-3 · Cited by 44
FOXO3 Modulates Endothelial Gene Expression and Function by Classical and Alternative Mechanisms
Czymai, T., Viemann, D., Sticht, C., Molema, G., Goebeler, M., & Schmidt, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056663 · Cited by 42
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 45
Lee, Y.-H., Yun, M. R., Kim, H. M., Jeon, B. H., Park, B.-C., Lee, B.-W., Kang, E. S., Lee, H. C., Park, Y. W., & Cha, B.-S. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.173 · Cited by 40
Piccinin, E., Peres, C. M., Bellafante, E., Ducheix, S., Pinto, C., Villani, G., & Moschetta, A. (2018) · Hepatology · doi:10.1002/hep.29484 · Cited by 43
Hong, Y. A., Bae, S. Y., Ahn, S. Y., Kim, J., Kwon, Y. J., Jung, W. Y., & Ko, G. J. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000481804 · Cited by 40
Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions
Liu, T., Wang, Y., Wang, Y., & Chan, A. M.-L. (2019) · Cancers · doi:10.3390/cancers11091247 · Cited by 43
The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription
Shlomai, A., & Shaul, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.078 · Cited by 40
PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
Liu, Y. X., Cheng, F., Luo, Y., Zhan, Z., Hu, P., Ren, H., Tang, H., & Peng, M. (2017) · BioMed Research International · doi:10.1155/2017/8234507 · Cited by 43
Zhang, H., Li, Y., An, T., Huang, F.-X., Wang, M., Liu, C., Mao, J., & Zhang, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01697 · Cited by 40
Metformin: An Inhibitor of mTORC1 Signaling
Melnik, B. C., & Schmitz, G. (2014) · Cited by 45
New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans
Wawrzyniak, R., Mateo, J., Blanco, I., Izquierdo-García, J. L., Dudzik, D., Markuszewski, M. J., Peinado, V. I., Laclaustra, M., Barberà, J. A., Barbas, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160505 · Cited by 42
KLF10 transcription factor regulates hepatic glucose metabolism in mice
Yang, X., Chen, Q., Sun, L., Zhang, H., Yao, L., Cui, X., Gao, Y., Fang, F., & Chang, Y. (2017) · Diabetologia · doi:10.1007/s00125-017-4412-2 · Cited by 39
“In turn, PGC-1α stimulates the expression of Pck1 and G6pc, two key gluconeogenic genes encoding PEPCK and glucose-6-phosphatase (G6Pase), respectively, through directly interacting with and coactivating several transcription factors such as hepatic nuclear factor-4 (HNF4), glucocorticoid receptor (GR), and forkhead b…”
BackgroundDonado-Pestana, C. M., dos Santos-Donado, P. R., Daza, L. D., Belchior, T., Festuccia, W. T., & Genovese, M. I. (2017) · Food Research International · doi:10.1016/j.foodres.2017.10.011 · Cited by 41
Mechanisms controlling the anti-neoplastic functions of FoxO proteins
Hou, T., Li, Z., Zhao, Y., & Zhu, W. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.007 · Cited by 40
Sajan, M. P., Lee, M. C., Foufelle, F., Sajan, J., Cleland, C., & Farese, R. V. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.12.005 · Cited by 43
Epigenetic-Transcriptional Regulation of Fatty Acid Metabolism and Its Alterations in Leukaemia
Maher, M., Diesch, J., Casquero, R., & Buschbeck, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00405 · Cited by 42
“…TFs involved in the up-regulation of oxidative metabolism, including PPARα and PPAR∂ (Vega et al., 2000), forkhead box protein O1 (FOXO1; Puigserver et al., 2003), nuclear respiratory factors (NRF1 and NRF2; Wu et al., 1999), as well as the lipogenic regulator,…”
BackgroundControl of Hepatic Gluconeogenesis by the Promyelocytic Leukemia Zinc Finger Protein
Chen, S., Qian, J., Shi, X., Gao, T., Liang, T., & Liu, C. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1164 · Cited by 44
Roles of Protein Arginine Methyltransferases in the Control of Glucose Metabolism
Han, H.-S., Choi, D., Choi, S., & Koo, S. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.435 · Cited by 38
Cell-Type Specific Expression of a Dominant Negative PKA Mutation in Mice
Willis, B. S., Niswender, C. M., Su, T., Amieux, P. S., & McKnight, G. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018772 · Cited by 42
Yang, Z., Roth, K., Agarwal, M., Liu, W., & Petriello, M. C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108633 · Cited by 41
Martin, A., Castells, J., Allibert, V., Emerit, A., Zolotoff, C., Cardot‐Ruffino, V., Gallot, Y. S., Vernus, B., Chauvet, V., Bartholin, L., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12939 · Cited by 47
Putting the Brakes on Insulin Signaling
Saltiel, A. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr031668 · Cited by 38
PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase
Barber, D. F., Alvarado-Kristensson, M., González-García, A., Pulido, R., & Carrera, A. C. (2006) · Science s STKE · doi:10.1126/stke.3622006pe49 · Cited by 42
Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703656 · Cited by 40
Ezrokhi, M., Luo, S., Trubitsyna, Y., & Cincotta, A. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-104 · Cited by 42
“Moreover, hepatic PGC1α, a transcription factor that associates with FOXO1α to induce transcription of gluconeogenic enzymes, induces hepatic insulin resistance and is itself elevated in diabetes [89-91,93-96,105].”
Tavares, C. D. J., Sharabi, K., Dominy, J. E., Lee, Y., Isasa, M., Orozco, J. M., Jedrychowski, M. P., Kamenecka, T. M., Griffin, P. R., Gygi, S. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706200 · Cited by 42
“This transcriptional coactivator interacts with hepatocyte nuclear factor 4 (HNF4 ) and forkhead box protein O1 (FOXO1) to promote transcription of phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) genes, which encode two enzymes that significantly moderate gluconeogenesis (23, 24).”
BackgroundSelf-citationGoyal, N., Tiwary, S., Kesharwani, D., & Datta, M. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1718-6 · Cited by 43
Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37
“The effect of MKP-3 on hepatic glucose output is implemented through dephosphorylation and activation of FOXO1, a forkhead transcription factor with a well-established role in turning on the gluconeogenic program (Wu et al., 2010; Daitoku et al., 2003; Puigserver et al., 2003).”
BackgroundSpecificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology
Yerra, V. G., & Drosatos, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054682 · Cited by 40
Xu, H., Moni, M. A., & Lió, P. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.08.010 · Cited by 40
Neogi, U., Elaldı, N., Appelberg, S., Ambikan, A. T., Kennedy, E., Dowall, S., Bağcı, B., Gupta, S., Murillo, J. R., Akusjärvi, S. S., et al. (2022) · eLife · doi:10.7554/elife.76071 · Cited by 40
Tessier, S. N., Zhang, J., Biggar, K. K., Wu, C., Pifferi, F., Perret, M., & Storey, K. B. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.03.006 · Cited by 38
“However, gluconeogenesis is typically required for survival during prolonged fasting [39] and plays a noted role in mammalian models of hibernation [40].”
BackgroundEffect of Biotin Treatment on Hepatic Gene Expression in Streptozotocin-Induced Diabetic Rats
Sugita, Y., Shirakawa, H., Sugimoto, R., Furukawa, Y., & Komai, M. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70781 · Cited by 37
Tff3, as a Novel Peptide, Regulates Hepatic Glucose Metabolism
Xue, Y., Shen, L., Cui, Y., Zhang, H., Chen, Q., Cui, A., Fang, F., & Chang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075240 · Cited by 37
Activating AKT2 Mutation: Hypoinsulinemic Hypoketotic Hypoglycemia
Arya, V. B., Flanagan, S. E., Schober, E., Rami-Merhar, B. M., Ellard, S., & Hussain, K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3228 · Cited by 38
Dietary fat, genes and insulin sensitivity
López‐Miranda, J., Pérez‐Martínez, P., Marín, C., Fuentes, F. J., Delgado‐Lista, J., & Pérez‐Jiménez, F. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0138-1 · Cited by 41
Neurocircuits integrating hormone and nutrient signaling in control of glucose metabolism
Rother, E., Könner, A. C., & Brüning, J. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00685.2007 · Cited by 40
P53 negatively regulates the transcriptional activity of FOXO3a under oxidative stress
Miyaguchi, Y., Tsuchiya, K., & Sakamoto, K. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.04.017 · Cited by 40
“FOXO activity is also controlled by PPAR-g, PGC-1a (Puigserver et al., 2003), and C/EBP-b (Christian et al., 2002), resulting in the regulation of fatty acid metabolism in adipocytes.”
Backgroundde Souza, C. T., ARAUJO, E. P. D., Prada, P. O., Saad, M. J. A., Boschero, A. C., & Velloso, L. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1866-4 · Cited by 49
“As a transcriptional coactivator, PGC1α has several functional domains that participate in protein–protein interaction with PPARγ [5], PPARα [6], nuclear respiratory factor [7], cyclic AMP response element binding protein (CREB)-binding protein [8], hepatocyte nuclear factor-4α (HNF-4α) [9, 10], forkhead transcription…”
BackgroundHepatic gluconeogenesis and regulatory mechanisms in lactating ruminants: A literature review
Wang, G., Zhu, Y., Feng, D., Yao, J., Cao, Y., & Deng, L. (2024) · Animal Research and One Health · doi:10.1002/aro2.80 · Cited by 39
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 44
Gene–Nutrient Interactions in the Metabolic Syndrome
Phillips, C. M., Tierney, A. C., & Roche, H. M. (2008) · Lifestyle Genomics · doi:10.1159/000112461 · Cited by 42
“PKB also regulates the peroxisome proliferator-activated receptor γ (PPARγ) coactivator (PGC1) [”
Backgroundde Moura, L. P., Pauli, L. S. S., Cintra, D. E., de Souza, C. T., da Silva, A. S. R., Marinho, R., de Melo, M. A. R., Ropelle, E. R., & Pauli, J. R. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-8 · Cited by 42
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or expression of gluconeogenic genes such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase (PEPCK and G6Pase) [4-6].”
BackgroundmicroRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
Langlet, F., Tarbier, M., Haeusler, R. A., Camastra, S., Ferrannini, E., Friedländer, M. R., & Accili, D. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.003 · Cited by 39
Self-citationKawata, K., Hatano, A., Yugi, K., Kubota, H., Sano, T., Fujii, M., Tomizawa, Y., Kokaji, T., Tanaka, K. Y., Uda, S., et al. (2018) · iScience · doi:10.1016/j.isci.2018.07.022 · Cited by 40
PCAF fine‐tunes hepatic metabolic syndrome, inflammatory disease, and cancer
Wang, T., Yao, W., Shao, Y., Zheng, R., & Huang, F. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13877 · Cited by 37
Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1
Wang, S., Ai, H., Liu, L., Zhang, X., Gao, F., Zheng, L., Yi, J., Sun, L., Yu, C., Zhao, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2019 · Cited by 37
“FOXO1 has been shown to bind directly to the promoters of gluconeogenic genes and induce G6pase and PEPCK transcription, thereby enhancing hepatic glucose output under fasting conditions (17, 26, 31).”
BackgroundPogoda-Wesołowska, A., Chmielewska, N., Maciejak, P., & Szyndler, J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200705225821 · Cited by 38
Blanco, A. M., Bertucci, J. I., Hatef, A., & Unniappan, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67535-z · Cited by 40
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Verma, S., Prajapati, K. S., Kushwaha, P. P., Shuaib, M., Singh, A. K., Kumar, S., & Gupta, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.45 · Cited by 48
Zheng, H., Wan, J., Shan, Y., Song, X., Jin, J., Su, Q., Chen, S., Lu, X., Yang, J., Li, Q., et al. (2021) · Theranostics · doi:10.7150/thno.46882 · Cited by 39
PGC-1α, un co-activateur transcriptionnel impliqué dans le métabolisme
Tiraby, C., & Langin, D. (2005) · médecine/sciences · doi:10.1051/medsci/200521149 · Cited by 52
“PGC-1α augmente la production de glucose dans les hépatocytes in vitro ou in vivo et coactive la transcription des enzymes PEPCK, F-1,6-BPase et G-6-Pase, en coopération avec les facteurs de transcription Foxo1 [13], HNF-4α ou le récepteur des glucocorticoïdes [4, 36].”
BackgroundMcCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.043 · Cited by 41
Inhibition of Forkhead Box O1 Protects Pancreatic β-Cells against Dexamethasone-Induced Dysfunction
Zhang, X., Wei, Y. Q., Lv, J., Zhu, Y., Zhang, J., Fang, C., Zhang, R., Yang, T., Sun, Y., & Han, X. (2009) · Endocrinology · doi:10.1210/en.2009-0343 · Cited by 42
Felder, T. K., Soyal, S. M., Oberkofler, H., Hahne, P., Auer, S., Weiss, R., Gadermaier, G., Miller, K. N., Krempler, F., Esterbauer, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227496 · Cited by 39
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance
Shlomai, A., Rechtman, M. M., Burdelova, E. O., Zilberberg, A., Hoffman, S., Solar, I., Fishman, S., Halpern, Z., & Sklan, E. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.021 · Cited by 41
Ren, G., Rimando, A. M., & Mathews, S. T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.035 · Cited by 38
Goldsworthy, M., Bai, Y., Li, C.-M., Ge, H., Lamas, E., Hilton, H., Esapa, C. T., Baker, D., Baron, W., Juan, T., et al. (2016) · Diabetes · doi:10.2337/db15-1276 · Cited by 35
Maternal nutrient metabolism in the liver during pregnancy
Fang, H., Li, Q., Wang, H., Ren, Y., Zhang, L., & Yang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1295677 · Cited by 41
A central role for hypoxia-inducible factor (HIF)-2α in hepatic glucose homeostasis
Ramakrishnan, S. K., & Shah, Y. M. (2017) · Nutrition and Healthy Aging · doi:10.3233/nha-170022 · Cited by 39
Mutt, S. J., Raza, G. S., Mäkinen, M. J., Keinanen-Kiukaanniemi, S. M., Järvelin, M., & Herzig, K. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900728 · Cited by 39
Butler, A. E., Ramachandran, V., Sathyapalan, T., David, R. M., Gooderham, N. J., Benurwar, M., Dargham, S. R., Hayat, S., Najafi-Shoushtari, S. H., & Atkin, S. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00206 · Cited by 46
Wan, X., Zhu, X., Wang, H., Feng, Y., Zhou, W., Liu, P., Shen, W., Zhang, L., Liu, L., Li, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902476r · Cited by 35
The metabolic-epigenetic nexus in type 2 diabetes mellitus
Davison, G. W., Irwin, R. E., & Walsh, C. P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.025 · Cited by 41
Can Brown Fat Win the Battle Against White Fat?
Elattar, S., & Ande, S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24986 · Cited by 39
“…thermogenesis in the BAT, it is also deeply involved in a number of other cellular mechanisms such as glucose, and fatty acid metabolism, mitochondrial biogenesis, and oxidative metabolism in other organs such as muscle, liver, heart, and brain (Puigserver et al., 2003; Austin and St-Pierre, 2012).”
BackgroundThe role of transcriptional regulators in central control of appetite and body weight
Coppari, R., Ramadori, G., & Elmquist, J. K. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1070 · Cited by 41
Lima, A. F., Ropelle, E. R., Pauli, J. R., Cintra, D. E., Frederico, M. J. S., Pinho, R. A., Velloso, L. A., & de Souza, C. T. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21833 · Cited by 41
“In loss- and gain-of-function experiments in mice, Foxo1 has been shown to promote hepatic glucose production (Pagliassotti et al., 2002; Puigserver et al., 2003).”
BackgroundMisra, J., Kim, D., Jung, Y. S., Kim, H. B., Kim, Y., Yoo, E.-K., Kim, B. G., Kim, S., Lee, I., Harris, R. A., et al. (2016) · Diabetes · doi:10.2337/db15-1523 · Cited by 39
Grempler, R., Kienitz, A., Werner, T., MEYER, M., Barthel, A., AILETT, F., Sutherland, C. D., Walther, R., & Schmoll, D. (2004) · Biochemical Journal · doi:10.1042/bj20040160 · Cited by 42
Vaughan, R. A., Mermier, C. M., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0301-4 · Cited by 34
Choi, S., Yoon, H., Oh, K.-S., Oh, Y. T., Kim, Y. I., Kang, I., & Youn, J. H. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.013 · Cited by 37
“In particular, FOXO1 is expressed in insulin-sensitive tissues such as liver, skeletal muscle, and adipose tissue and has been implicated in the regulation of insulin action in these tissues [13-15].”
CD38-mediated Ca2+ signaling contributes to glucagon-induced hepatic gluconeogenesis
Rah, S., & Kim, U. (2015) · Scientific Reports · doi:10.1038/srep10741 · Cited by 34
PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism
Lee, J., Hernández, M. A. S., Auen, T., Mucka, P., Lee, J., & Özcan, U. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.010 · Cited by 36
The KLF14 transcription factor regulates hepatic gluconeogenesis in mice
Wang, L., Tong, X., Gu, F., Zhang, L., Chen, W., Cheng, X., Xie, L., Chang, Y., & Zhang, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000184 · Cited by 41
“PGC-1 transactivates gluconeogenic gene expression by coactivating a variety of transcription factors, including hepatic nuclear factor-4 (HNF4 ), glucocorticoid receptor, forkhead box O1 (FOXO1), and cAMP-responsive element–binding protein (22).”
BackgroundLee, J.-M., Han, H.-S., Jung, Y. S., Harris, R. A., Koo, S., & Choi, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002196 · Cited by 35
Dittmann, A., Kennedy, N. J., Soltero, N. L., Morshed, N., Mana, M., Yilmaz, Ö. H., Davis, R. J., & White, F. M. (2019) · Molecular Systems Biology · doi:10.15252/msb.20198849 · Cited by 37
“…with features associated with insulin resistance in vivo , PA but not OA attenuated signaling through Akt as measured by pAkt-S473, increased mRNA levels of the gluconeogenic enzyme glucose-6-phosphatase, and led to elevated ROS levels in vitro (Schmoll et al , 2000; Puigserver et al , 2003).”
BackgroundA kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis
Ji, Y., Wang, Y., Li, P.-L., Cai, L., Wang, X., Bai, L., Liu, Z., Tian, H., Tian, S., Zhang, P., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.006 · Cited by 34
Chen, Y., Gleaton, J., Yang, Y., Dhayalan, B., Phillips, N. B., Liu, Y., Broadwater, L., Jarosinski, M. A., Chatterjee, D., Lawrence, M. C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103518118 · Cited by 38
Reifsnyder, P. C., Flurkey, K., Doty, R. A., Calcutt, N. A., Koza, R. A., & Harrison, D. E. (2022) · Aging Cell · doi:10.1111/acel.13666 · Cited by 37
“Such downregulation is generally associated with diminished gluconeogenesis (Puigserver et al., 2003), yet RAPA- treatment elevated circulating glucose, compared to controls, measured during a short- term fast that preceded blood sampling (Figure 4c).”
BackgroundNovel repressor regulates insulin sensitivity through interaction with Foxo1
Nakae, J., Cao, Y., Hakuno, F., Takemori, H., Kawano, Y., Sekioka, R., Abe, T., Kiyonari, H., Tanaka, T., Sakai, J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.97 · Cited by 38
“For example, PPAR-g co-activator 1 a (PGC-1 a ) interacts with Foxo1 and stimulates gluconeogenesis in the liver (Puigserver et al , 2003).”
The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Constable, S., Wollaston‐Hayden, E. E., Teo, C. F., Morris, A., & Wells, L. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210790226465 · Cited by 35
Skeleton and Glucose Metabolism: A Bone-Pancreas Loop
Faienza, M. F., Luce, V., Ventura, A., Colaianni, G., Colucci, S. C., Cavallo, L., Grano, M., & Brunetti, G. (2015) · International Journal of Endocrinology · doi:10.1155/2015/758148 · Cited by 38
“These phosphatases can regulate Ocn activity and glucose homeostasis by acting on the insulin signaling pathway in the OBs [21, 23, 24].”
Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity
Kudo, T., Shimada, T., Toda, T., Igeta, S., Suzuki, W., Ikarashi, N., Ochiai, W., Ito, K., Aburada, M., & Sugiyama, K. (2009) · Xenobiotica · doi:10.1080/00498250903242592 · Cited by 38
Cook, J. R., Matsumoto, M., Banks, A. S., Kitamura, T., Tsuchiya, K., & Accili, D. (2015) · Diabetes · doi:10.2337/db14-1506 · Cited by 35
Self-citationTranscriptional Regulation of Glucose Sensors in Pancreatic β Cells and Liver
Im, S., Kim, S., Kim, H., & Ahn, Y. (2006) · Current Diabetes Reviews · doi:10.2174/157339906775473581 · Cited by 38
“gluconeogenic gene suppression by insulin is known to be mediated by the insuin-Foxo1 pathway [50].”
BackgroundYu, L., Wang, Z., Huang, M., Li, Y., Zeng, K., Lei, J., Hu, H., Chen, B., Lü, J., Xie, W., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.10.001 · Cited by 34
Wang, Y.-C., Ma, H.-D., Yin, X.-Y., Wang, Y., Liu, Q.-Z., Yang, J.-B., Shi, Q.-H., Sun, B., Gershwin, M. E., & Lian, Z. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8531-1 · Cited by 35
Luo, K., Huang, W., Qiao, L., Zhang, X., Yan, D., Ning, Z.-Y., Ma, C., Dang, H., Wang, D., Guo, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.017 · Cited by 34
He, Q., Luo, J., Wu, J., Yao, W., Li, Z., Wang, H., & Xu, H. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05237 · Cited by 33
Zhang, Q., Li, R., Wang, L., Zhang, T., Qian, D., Tang, D., He, C., Wu, C., & Li, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1089558 · Cited by 34
“, 2010), and inhibiting hepatic gluconeogenesis (Puigserver et al., 2003; Matsumoto et al., 2007).”
Pateras, I. S., Williams, C., Gianniou, D. D., Margetis, A. T., Avgeris, M., Rousakis, P., Legaki, A., Mirtschink, P., Zhang, W., Panoutsopoulou, K., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03935-9 · Cited by 43
Draper, S. J., Kirigiti, M. A., Glavas, M. M., Grayson, B. E., Chong, C. N. A., Jiang, B. S., Smith, M. S., Zeltser, L. M., & Grove, K. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.082 · Cited by 40
“NPY gene transcription in the ARH is regulatedbyFOXO1which is known to interactwithPGC1α (Puigserver et al., 2003).”
BackgroundGSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1
Sakamaki, J.-I., Daitoku, H., Kaneko, Y., Hagiwara, A., Ueno, K., & Fukamizu, A. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.660531 · Cited by 38
“levels of PGC-1α, a transcriptional coactivator that coordinately acts with HNF4α and FOXO1 to augment G6Pase and PEPCK transcription (4,5,28), was also decreased in GSK3β knockdown cells (Figure 1D).”
BackgroundWu, C., Khan, S. A., Peng, L.-J., Li, H., Carmella, S. G., & Lange, A. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00126.2006 · Cited by 42
Sun, L. D., Yang, Z., Jin, F., Zhu, X., Qu, Y. C., Shi, X., & Wang, L. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01949.x · Cited by 38
Dual-Specific Protein and Lipid Phosphatase PTEN and Its Biological Functions
Tu, T., Chen, J., Chen, L., & Stiles, B. L. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036301 · Cited by 36
“2007); and (3) glucose metabolism via the AS160 Rab GTPase-activating protein (GAP), to control redistribution of glucose transporter 4 from intracellular compartments to the plasma membrane, as well as forkhead transcription factor to control hepatic gluconeogenesis (Puigserver et al. 2003; Eguez et al. 2005; Mîinea…”
BackgroundApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis
Stein, S., Lohmann, C., Handschin, C., Stenfeldt, E., Borén, J., Lüscher, T. F., & Matter, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013539 · Cited by 35
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.